More than 140,000 bottles of a popular drug commonly prescribed to reduce cholesterol have been recalled for a defect that ...

GLP-1 drugs were initially developed for type 2 diabetes but are now widely used to treat obesity. Novo Nordisk and Eli Lilly lead in GLP-1 drug production, with others like Viking Therapeutics ...

The drug, one of the few nonhormonal options for menopausal women, reduced hot flashes and night sweats, and appears to help with sleep issues. By Nina Agrawal and Maggie Astor The Food and Drug ...

A Colchester man has pleaded guilty to being concerned in the supply of class A drugs. Michael Ferrie, 38, of Greenfield Houses, Birch, Colchester, appeared at Ipswich Crown Court charged with three ...

Insider claims people have found a way to get around the move BOSSES of the new Harry Potter TV series have hired sniffer dogs over fears of drugs being used on set. They suspect trades-people working ...

Samsung Bioepis and Phrontline will co-develop two investigational antibody-drug conjugate (ADC) assets directed against targets expressed in a broad range of cancers Collaboration will add a new ...

A drugs baron who paid for his daughter's private school fees with envelopes of cash he made while working as a wholesale supplier to gangs has been jailed for 18 years and nine months. Gregory Bell, ...

Scientists have identified a new anti-ageing drug class that works by acting on a key gut bacteria process, an advance that may lead to ways to prolong lifespan in humans. Researchers from Queen Mary ...

DMX-1001 (noribogaine) is being developed to treat AUD through a potential novel mechanism that targets multiple areas of the central nervous system and promotes neuroplasticity AUD impacts more than ...

Paul Roberts’ story “Everything must go: Bartell Drugs, an institution for 135 years, fades away” (Sept. 30, A1) brings back memories. Bartell Drugs’ successes, in my opinion, resulted from a ...

The GLP-1 agonist at the center of Pfizer’s upfront $4.9 billion buyout of Metsera last week has been tied to 14.1% weight loss at 28 weeks as well as “potentially class-leading tolerability,” ...

SAN DIEGO, Calif.--(BUSINESS WIRE)--Avenzo Therapeutics, Inc. (“Avenzo”), a clinical-stage biotechnology company developing next-generation oncology therapies, today announced initiation of a Phase ...